Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Toll like receptor 4 mediates the inhibitory effect of SARS-CoV-2 spike protein on proximal tubule albumin endocytosis.

Autor: Silva-Aguiar RP; Carlos Chagas Filho Biophysics Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Teixeira DE; Carlos Chagas Filho Biophysics Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Peruchetti DB; Carlos Chagas Filho Biophysics Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Peres RAS; Carlos Chagas Filho Biophysics Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Alves SAS; Carlos Chagas Filho Biophysics Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Calil PT; Paulo de Góes Microbiology Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Arruda LB; Paulo de Góes Microbiology Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Costa LJ; Paulo de Góes Microbiology Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Silva PL; Carlos Chagas Filho Biophysics Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Rio de Janeiro Innovation Network in Nanosystems for Health-NanoSAÚDE/FAPERJ, Rio de Janeiro, Brazil; National Institute of Science and Technology for Regenerative Medicine, Rio de Janeiro, Brazil., Schmaier AH; Department of Medicine, School of Medicine, Case Western Reserve University, Cleveland, OH, USA; University Hospitals Cleveland Medical Center, Cleveland, OH, USA., Rocco PRM; Carlos Chagas Filho Biophysics Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Rio de Janeiro Innovation Network in Nanosystems for Health-NanoSAÚDE/FAPERJ, Rio de Janeiro, Brazil; National Institute of Science and Technology for Regenerative Medicine, Rio de Janeiro, Brazil., Pinheiro AAS; Carlos Chagas Filho Biophysics Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Rio de Janeiro Innovation Network in Nanosystems for Health-NanoSAÚDE/FAPERJ, Rio de Janeiro, Brazil., Caruso-Neves C; Carlos Chagas Filho Biophysics Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Rio de Janeiro Innovation Network in Nanosystems for Health-NanoSAÚDE/FAPERJ, Rio de Janeiro, Brazil; National Institute of Science and Technology for Regenerative Medicine, Rio de Janeiro, Brazil. Electronic address: caruso@biof.ufrj.br.

Publikováno v: Biochimica et biophysica acta. Molecular basis of disease [Biochim Biophys Acta Mol Basis Dis] 2024 Jun; Vol. 1870 (5), pp. 167155. Date of Electronic Publication: 2024 Apr 04.

Current sampling and sequencing biases of Lassa mammarenavirus limit inference from phylogeography and molecular epidemiology in Lassa fever endemic regions.

Autor: Arruda LB; Division of Infection and Immunity, Centre for Clinical Microbiology, University College London, London, United Kingdom., Free HB; The Royal Veterinary College, University of London, Hatfield, United Kingdom., Simons D; The Royal Veterinary College, University of London, Hatfield, United Kingdom., Ansumana R; School of Community Health Sciences, Njala University, Bo, Sierra Leone., Elton L; Division of Infection and Immunity, Centre for Clinical Microbiology, University College London, London, United Kingdom., Haider N; The Royal Veterinary College, University of London, Hatfield, United Kingdom., Honeyborne I; Division of Infection and Immunity, Centre for Clinical Microbiology, University College London, London, United Kingdom., Asogun D; Ekpoma and Irrua Specialist Teaching Hospital, Ambrose Alli University, Irrua, Nigeria., McHugh TD; Division of Infection and Immunity, Centre for Clinical Microbiology, University College London, London, United Kingdom., Ntoumi F; Fondation Congolaise Pour la Recherche Médicale (FCRM), Brazzaville, Republic of Congo.; Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany., Zumla A; Division of Infection and Immunity, Centre for Clinical Microbiology, University College London, London, United Kingdom.; NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, United Kingdom., Kock R; The Royal Veterinary College, University of London, Hatfield, United Kingdom.

Publikováno v: PLOS global public health [PLOS Glob Public Health] 2023 Nov 08; Vol. 3 (11), pp. e0002159. Date of Electronic Publication: 2023 Nov 08 (Print Publication: 2023).